<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38320835</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study.</ArticleTitle><Pagination><StartPage>e075185</StartPage><MedlinePgn>e075185</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e075185</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2023-075185</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To define macro symptoms of long COVID and to identify predictive factors, with the aim of preventing the development of the long COVID syndrome.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A single-centre longitudinal prospective cohort study conducted from May 2020 to October 2022.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The study was conducted at Luigi Sacco University Hospital in Milan (Italy). In May 2020, we activated the ARCOVID (Ambulatorio Rivalutazione COVID) outpatient service for the follow-up of long COVID.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Hospitalised and non-hospitalised patients previously affected by COVID-19 were either referred by specialists or general practitioners or self-referred.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">During the first visit, a set of questions investigated the presence and the duration of 11 symptoms (palpitations, amnesia, headache, anxiety/panic, insomnia, loss of smell, loss of taste, dyspnoea, asthenia, myalgia and telogen effluvium). The follow-up has continued until the present time, by sending email questionnaires every 3 months to monitor symptoms and health-related quality of life.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOME MEASURES" NlmCategory="METHODS">Measurement of synthetic scores (aggregation of symptoms based on occurrence and duration) that may reveal the presence of long COVID in different clinical macro symptoms. To this end, a mixed supervised and empirical strategy was adopted. Moreover, we aimed to identify predictive factors for post-COVID-19 macro symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the first and second waves of COVID-19, 575 and 793 patients (respectively) were enrolled. Three different post-COVID-19 macro symptoms (neurological, sensorial and physical) were identified. We found significant associations between post-COVID-19 symptoms and (1) the patients' comorbidities, and (2) the medications used during the COVID-19 acute phase. ACE inhibitors (OR=2.039, 95% CI: 1.095 to 3.892), inhaled steroids (OR=4.08, 95%&#x2009;CI: 1.17 to 19.19) and COVID therapies were associated with increased incidence of the neurological macro symptoms. Age (OR=1.02, 95%&#x2009;CI: 1.01 to 1.04), COVID-19 severity (OR=0.42, 95% CI: 0.21 to 0.82), number of comorbidities (OR=1.22, 95% CI: 1.01 to 1.5), metabolic (OR=2.52, 95% CI: 1.25 to 5.27), pulmonary (OR=1.87, 95% CI: 1.10 to 3.32) and autoimmune diseases (OR=4.57, 95% CI: 1.57 to 19.41) increased the risk of the physical macro symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Being male was the unique protective factor in both waves. Other factors reflected different medical behaviours and the impact of comorbidities. Evidence of the effect of therapies adds valuable information that may drive future medical choices.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borgonovo</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5796-671X</Identifier><AffiliationInfo><Affiliation>Infectious Diseases, Luigi Sacco University Hospital, Milano, Italy borgonovo.fabio@asst-fbf-sacco.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovaglio</LastName><ForeName>Pietro Giorgio</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Interuniversity Research Centre on Public Services (CRISP), Department of Statistics and Quantitative Methods, University Bicocca-Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Luigi Sacco University Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Interuniversity Research Centre on Public Services (CRISP), Department of Statistics and Quantitative Methods, University Bicocca-Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cossu</LastName><ForeName>Maria Vittoria</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Luigi Sacco University Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzardini</LastName><ForeName>Giuliano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Luigi Sacco University Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vittadini</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Interuniversity Research Centre on Public Services (CRISP), Department of Statistics and Quantitative Methods, University Bicocca-Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capetti</LastName><ForeName>Amedeo Ferdinando</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Luigi Sacco University Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">general medicine (see internal medicine)</Keyword><Keyword MajorTopicYN="N">infectious diseases</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38320835</ArticleId><ArticleId IdType="pmc">PMC10860093</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2023-075185</ArticleId><ArticleId IdType="pii">bmjopen-2023-075185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus (COVID-19) Dashboard . WHO Coronavirus (COVID-19) dashboard with vaccination data. Available: https://Covid19.who.int [Accessed 26 Aug 2022].</Citation></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, et al. . Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020;324:782&#x2013;93. 10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . COVID-19 clinical management: living guidance [World Health Organization]. 2021. Available: https://apps.who.int/iris/handle/10665/338882 [Accessed 30 Dec 2022].</Citation></Reference><Reference><Citation>A clinical case definition of post-COVID-19 condition by a Delphi consensus 6 October 2021 [WHO]. Available: https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?sequence=1&amp;isAllowed=y [Accessed 30 Dec 2022].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, et al. . Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine 2021;36:100899. 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 2021;4:e2111417. 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Joshi M, Davies G, et al. . Design of the pilot, proof of concept REMOTE-COVID trial: REMOTE monitoring use in suspected cases of COVID-19 (SARS-CoV-2). Pilot Feasibility Stud 2021;7:62. 10.1186/s40814-021-00804-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40814-021-00804-4</ArticleId><ArticleId IdType="pmc">PMC7933391</ArticleId><ArticleId IdType="pubmed">33673868</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindrola-Padros C, Singh KE, Sidhu MS, et al. . Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review. EClinicalMedicine 2021;37:100965. 10.1016/j.eclinm.2021.100965</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100965</ArticleId><ArticleId IdType="pmc">PMC8219406</ArticleId><ArticleId IdType="pubmed">34179736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, et al. . Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med 2021;174:576&#x2013;8. 10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 2022;28:1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al. . Long covid-mechanisms, risk factors, and management. BMJ 2021;374:1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis 2022;226:1593&#x2013;607. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Verduri A, Short R, Carter B, et al. . Comparison between first and second wave of COVID-19 outbreak in older people: the COPE multicentre European observational cohort study. Eur J Public Health 2022;32:807&#x2013;12. 10.1093/eurpub/ckac108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckac108</ArticleId><ArticleId IdType="pmc">PMC9452163</ArticleId><ArticleId IdType="pubmed">35997587</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttensch&#xf8;n HN, Lynggaard V, Sandb&#xf8;l SG, et al. . Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study. BMC Infect Dis 2022;22:423. 10.1186/s12879-022-07413-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07413-3</ArticleId><ArticleId IdType="pmc">PMC9063242</ArticleId><ArticleId IdType="pubmed">35505306</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanca D, Nicolosi S, Bandera A, et al. . Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study. Intern Emerg Med 2022;17:2219&#x2013;28. 10.1007/s11739-022-03052-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03052-3</ArticleId><ArticleId IdType="pmc">PMC9377666</ArticleId><ArticleId IdType="pubmed">35970982</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, et al. . Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens 2022;11:269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Guijarro C, Plaza-Canteli S, et al. . Prevalence of post-COVID-19 cough one year after SARS-CoV-2 infection: a multicenter study. Lung 2021;199:249&#x2013;53. 10.1007/s00408-021-00450-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00450-w</ArticleId><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamberini L, Mazzoli CA, Prediletto I, et al. . Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study. Respir Med 2021;189:106665. 10.1016/j.rmed.2021.106665</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106665</ArticleId><ArticleId IdType="pmc">PMC8531241</ArticleId><ArticleId IdType="pubmed">34717097</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, et al. . Symptoms and health outcomes among survivors of COVID-19 infection 1 Year after discharge from hospitals in Wuhan, China. JAMA Netw Open 2021;4:e2127403. 10.1001/jamanetworkopen.2021.27403</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021;398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Yang C, An X, et al. . Follow-up study on COVID-19 survivors one year after discharge from hospital. Int J Infect Dis 2021;112:173&#x2013;82. 10.1016/j.ijid.2021.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.017</ArticleId><ArticleId IdType="pmc">PMC8434916</ArticleId><ArticleId IdType="pubmed">34520845</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe1;n IP, Mart&#xed; CR, Sota DP de la, et al. . Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission. J Med Virol 2022;94:205&#x2013;10. 10.1002/jmv.27296</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27296</ArticleId><ArticleId IdType="pmc">PMC8662039</ArticleId><ArticleId IdType="pubmed">34436783</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemieniuk RA, Bartoszko JJ, Zeraatkar D, et al. . Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ 2020:m2980. 10.1136/bmj.m2980</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2980</ArticleId><ArticleId IdType="pmc">PMC7390912</ArticleId><ArticleId IdType="pubmed">32732190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv F, Gao X, Huang AH, et al. . Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States. EClinicalMedicine 2022;54:101671. 10.1016/j.eclinm.2022.101671</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101671</ArticleId><ArticleId IdType="pmc">PMC9500386</ArticleId><ArticleId IdType="pubmed">36168320</ArticleId></ArticleIdList></Reference><Reference><Citation>Griep MI, Van der Niepen P, Sennesael JJ, et al. . Odour perception in chronic renal disease. Nephrol Dial Transplant 1997;12:2093&#x2013;8. 10.1093/ndt/12.10.2093</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/12.10.2093</ArticleId><ArticleId IdType="pubmed">9351071</ArticleId></ArticleIdList></Reference><Reference><Citation>Regione Lombardia . Dashboard COVID-19. Available: https://www.regione.lombardia.it/wps/portal/istituzionale/HP/servizi-e-informazioni/cittadini/salute-e-prevenzione/coronavirus/dashboard-covid19 [Accessed 07 Nov 2023].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>